Physician profile
Jason Brown
NPI 1386752699
$516.49
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $53.88 · 2021: $75.98 · 2022: $149 · 2023: $56.10 · 2024: $40.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $96.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $96.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.61 | 2019-2022 | |
| Exeltis, USA INC. | $53.74 | 2019-2022 | |
| Lupin INC. | $53.58 | 2019-2020 | |
| Becton, Dickinson and Company | $47.32 | 2022 | |
| Therapeuticsmd, INC. | $40.41 | 2019 | |
| Ethicon US, LLC | $33.37 | 2023 | Enseal X1 |
| Hologic Sales and Service, LLC | $24.95 | 2022 | |
| Evofem Biosciences, INC. | $23.39 | 2021 | |
| Allergan, INC. | $23.35 | 2019-2020 | |
| Smith+Nephew, INC. | $22.73 | 2023 | Stravix Pl |
| Mayne Pharma Commercial LLC | $22.72 | 2022 | |
| Duchesnay USA Incorporated | $22.12 | 2019 | |
| Sumitomo Pharma America, INC. | $21.28 | 2024 | Myfembree |
| Meditrina | $19.02 | 2024 | |
| Avion Pharmaceuticals | $18.26 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $17.50 | 2021 | |
| Abbvie INC. | $17.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.